NCT01803646View on ClinicalTrials.gov

AM-101 in the Treatment of Acute Tinnitus 2

PHASE3CompletedINTERVENTIONAL
Enrollment

343

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

June 30, 2016

Study Completion Date

June 30, 2016

Conditions
Tinnitus
Interventions
DRUG

AM-101

AM-101 gel for intratympanic injection

DRUG

Placebo

Placebo gel for intratympanic injection

Trial Locations (1)

45227

Medpace, Cincinnati

Sponsors
All Listed Sponsors
lead

Auris Medical, Inc.

INDUSTRY

NCT01803646 - AM-101 in the Treatment of Acute Tinnitus 2 | Biotech Hunter | Biotech Hunter